India's AIDS Fight: A Crucial Crossroads as Breakthrough Drugs Hit Patent Walls

The Unseen Threat to Global Health: How Data Exclusivity Could Cripple Access to Affordable Medicines

The Pharma Giants' Bold Leap: Novo Nordisk and Eli Lilly Eyeing Direct Sales of Obesity Drugs to Employers

The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access

Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?

Eli Lilly Declares UK 'Worst in Europe' for Drug Prices, Threatening Patient Access to New Medicines

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

A New Dawn in Public Health: Expanding Access to Revolutionary HIV Prevention Across the U.S.